| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |